Acute Disseminated Encephalomyelitis (ADE)
Overview
  • Demyelinating disorder of the CNS that seems to be immune mediated.
  • Pathogenesis is not known.
  • Virus usually is not isolated from the nervous system, an allergic or autoimmune reaction is most likely.
  • Usually preceded by a viral syndrome or vaccinations.
  • Usually monophasic, but recurrent episodes may occur.
  • Diseases that may trigger the demyelination:
    • measles, rubella, Varicella-zoster, smallpox, mumps, influenza, parainfluenza, infectious mononucleosis, typhoid, mycoplasma infections, upper respiratory and other febrile disease
    • vaccination against measles, mumps, rubella, influenza, and rabies.
  • Most common overall cause: Nonspecific upper respiratory infections and Varicella infections.
Pathology
  • No change occurs in the external appearance of the brain or spinal cord.
  • Loss of myelin, with relative sparing of the axon.
  • Microscopic: perivenular lymphocytic and mononuclear cell infiltration and demyelination.
Symptoms and Signs
  • Meningeal signs are common early.
  • Subsequent symptoms and signs: related to the portion of the nervous system that is most severely damaged.
  • Any part of CNS may be affected.
  • Duration of active CNS disease varies from days to weeks.
Clinical testing
  • CSF pressure may be slightly elevated.
    • WBC: mild to moderate increase: 15 to 250 cells/mm3 with lymphocytes predominating.
    • Protein: normal or slightly elevated (35 to 150 mg/dl).
    • Glucose: normal
    • Oligoclonal bands are usually negative
    • Myelin basic protein level is usually increased.
  • EEG: abnormal in most cases, with slow frequency of 4 to 6 Hz and high voltage.   The abnormalities persist for several weeks after apparent clinical recovery.
  • CT head: After several days, the CT scan may show diffuse or scattered low-density lesions in the white matter, some of which may enhance with contrast.
  • MRI: increased signal intensity on T2 -weighted images.
Treatment
  • Several reports suggest that adrenocorticotropic hormone or corticosteroids reduces the severity of the neurologic defects.
  • Isolated case reports: plasmapharesis or IVIG used.
Prognosis
  • In patients who survive, the neurologic signs usually improve considerably, with about 90% having complete recovery.
  • The exception is measles, in which sequelae may occur in 20 to 50% of patients.
Further Readings
  • Acute disseminated encephalitis - Baylor
  • Kanter. DS. Plasmapheresis in fulminant acute disseminated encephalitis. Neurology. 1995;45:824-827
  • Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18-27.
  • Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995;45:824-827.

Back to MS information center

arrow_up.gif (599 bytes)